NOR-KLEB-NET / KLEB-GAP annual meeting in Lofoten, Sept 7-9 2022
September 7-9, 2022
The NOR-KLEB-NET and KLEB-GAP annual meeting was held in Lofoten in September 2022. Finally we could meet in real life for the annual meeting after three years of digital meetings. Both national and international partners and collaborators were able to travel to Ballstad in Lofoten, and we had a very successful meeting, both scientifically and social, in beautiful surroundings.
COVID-19: NOR-KLEB-NET workshop and KLEB-GAP meeting June 2020 postponed/held virtually
Because of the covid-19 pandemic, it will unfortunately not be possible to organise the KLEB-GAP/NOR-KLEB-NET meetings as planned in June. The KLEB-GAP meeting will therefore be held virtually 11-12th June, and the NOR-KLEB-NET meeting will be postponed until 2021. More info to come.
The Norwegian Research Council Grants Further Funding for NOR-KLEB-NET
August 2019
We are very happy to announce that we have been granted further funding to run the NOR-KLEB-NET network for another two years by the Norwegian Research Council! We are very excited about this, especially as several of the partners of NOR-KLEB-NET met last week at Sommarøy, where we ...
Bergen Research Foundation Grants 20MNOK to New Klebsiella Project
December 2018
The Klebsiella pneumoniae project KLEB-GAP is lead by PI Arnfinn Sundsfjord and Co-PI Iren Høyland Löhr. KLEB-GAP is a large, new project involving several Norwegian and international institutions who aim to provide new insights into the ecology, antmicrobial resistance and pathogenicity of Klebsiella pneumoniae. Klebsiella is a key driver in the global spread of antimicrobial resistance and a target for new approaches in diagnostics, surveillance and alternative therapeutics.
About Us
May 29, 2018
NOR-KLEB-NET: The Norwegian Klebsiella pneumoniae Network - Klebsiella pneumoniae population structure, virulence, and antimicrobial resistance in a One Health perspective.
Funded by the Norwegian Research Council.Klebsiella pneumoniae has emerged as a high-risk human pathogen due to its virulence and increasing levels of antimicrobial resistance (AMR), and has by WHO been defined as one of the multidrug resistant (MDR) bacteria posing the greatest threat ...